[go: up one dir, main page]

MXPA03009687A - DISPERSION COLOIDAL ACUOSA ESTABLE Y METODO DE PREPARACIoN. - Google Patents

DISPERSION COLOIDAL ACUOSA ESTABLE Y METODO DE PREPARACIoN.

Info

Publication number
MXPA03009687A
MXPA03009687A MXPA03009687A MXPA03009687A MXPA03009687A MX PA03009687 A MXPA03009687 A MX PA03009687A MX PA03009687 A MXPA03009687 A MX PA03009687A MX PA03009687 A MXPA03009687 A MX PA03009687A MX PA03009687 A MXPA03009687 A MX PA03009687A
Authority
MX
Mexico
Prior art keywords
colloidal dispersion
stable aqueous
preparing same
aqueous colloidal
preparing
Prior art date
Application number
MXPA03009687A
Other languages
English (en)
Inventor
Albert Lebugle
Original Assignee
Rhodia Chimie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodia Chimie Sa filed Critical Rhodia Chimie Sa
Publication of MXPA03009687A publication Critical patent/MXPA03009687A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004—Preparation of sols
    • B01J13/0008—Sols of inorganic materials in water

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Colloid Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03009687A 2001-04-27 2002-04-25 DISPERSION COLOIDAL ACUOSA ESTABLE Y METODO DE PREPARACIoN. MXPA03009687A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105749A FR2823993B1 (fr) 2001-04-27 2001-04-27 Dispersion colloidale aqueuse stable, son procede de preparation
PCT/FR2002/001441 WO2002087747A1 (fr) 2001-04-27 2002-04-25 Dispersion colloidale aqueuse stable, son procede de preparation

Publications (1)

Publication Number Publication Date
MXPA03009687A true MXPA03009687A (es) 2004-02-12

Family

ID=8862806

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009687A MXPA03009687A (es) 2001-04-27 2002-04-25 DISPERSION COLOIDAL ACUOSA ESTABLE Y METODO DE PREPARACIoN.

Country Status (6)

Country Link
US (1) US20040152789A1 (es)
EP (1) EP1381455A1 (es)
JP (1) JP2005500231A (es)
FR (1) FR2823993B1 (es)
MX (1) MXPA03009687A (es)
WO (1) WO2002087747A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316560A (pt) * 2002-11-26 2005-10-04 Nobex Corp Conjugado de composto natriurético, formulação farmacêutica, método de tratar uma condição, método de preparação do conjugado de composto natriurético, conjugado de peptìdeo pró-polinatriurético modificado, análogo de peptìdeo natriurético, análogo de hbnp, composto, e, método de preparar um composto
JP4412600B2 (ja) * 2004-09-14 2010-02-10 日本化学工業株式会社 アパタイトゾルおよびその製造方法
ITFI20060139A1 (it) * 2006-06-08 2007-12-09 Colorobbia Italia Idrossiapatite nanometrica, sue sospensioni preparazione ed uso.
US20100092364A1 (en) * 2008-10-10 2010-04-15 Rajendra Kumar Kasinath Surface Functionalized Colloidally Stable Spheroidal Nano-apatites Exhibiting Intrinsic Multi-functionality
JP5956925B2 (ja) 2010-03-31 2016-07-27 東洋水産株式会社 カルシウム剤およびその製造方法
WO2021112932A2 (en) * 2019-08-21 2021-06-10 Entegris, Inc. Improved formulations for high selective silicon nitride etch

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2605229A (en) * 1949-04-23 1952-07-29 Joseph K Marcus Calcium phosphate gels
US3027229A (en) * 1957-12-02 1962-03-27 Diamond Lab Method of preparing hydrated calcium phosphate gels
EP0322250B1 (en) * 1987-12-23 1991-10-09 Sumitomo Chemical Company, Limited Coating liquor containing hydroxyapatite and method for forming hydroxyapatite coating film using the same

Also Published As

Publication number Publication date
EP1381455A1 (fr) 2004-01-21
WO2002087747A1 (fr) 2002-11-07
JP2005500231A (ja) 2005-01-06
FR2823993B1 (fr) 2003-06-20
US20040152789A1 (en) 2004-08-05
FR2823993A1 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
TWI344978B (en) Aqueous, colloidal gas black suspension
MX272846B (es) Dispersion acuosa, metodo de produccion y su uso.
AU2002341195A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
AU2002332812A1 (en) Browser-to-browser, dom-based, peer-to-peer communication with delta synchronization
AU2002349407A1 (en) Communication information sharing system, communication information sharing method, communication information sharing program
IL148265A0 (en) Aqueous dispersion, process for its production and use
SI1385825T1 (sl) Substituirani 2-piridin-cikloheksan-1,4-diaminskiderivati
MXPA03008630A (es) Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
AU2002332712A1 (en) Component-based, adaptive stroke-order system
ZA200402472B (en) Method for preparing benzenesulfonyl compounds.
ZA200102070B (en) Process for preparing resorcinol derivatives.
AP2004003032A0 (en) Wireless multipurpose communication system.
AU2002313812A1 (en) Improved method for making an aqueous dispersion
HK1053116A1 (zh) 製備西洛他唑的過程
MXPA03009687A (es) DISPERSION COLOIDAL ACUOSA ESTABLE Y METODO DE PREPARACIoN.
ZA200208346B (en) Polyamide nucleic acid derivatives, agents and methods for producing the same.
MXPA03007384A (es) Emulsificantes, especialmente a base de poliisobutilenaminas.
IL156162A0 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof.
MXPA03000664A (es) Derivados n-sustituidos del acido 1-amino-1, 1-dialquilcarboxilico.
AU2002328285A1 (en) Method for producing an essentially chlorite-free, stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
AU2001268981A1 (en) Method for producing 2-chloro-5-chloromethyl-1,3-thiazole
AU2002256766A1 (en) Stable aqueous colloidal dispersion, method for preparing same
AU2002241271A1 (en) Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
AU6984900A (en) Valve, especially radiator valve
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal